Tech Company M&A Transactions
BioVex Acquisition
Headquartered in Woburn, BioVex was acquired by Amgen. Amgen said the transaction price was $1 billion.
Transaction Overview
Company Name
Acquired By
Announced On
1/25/2011
Transaction Type
M&A
Amount
$1,000,000,000
M&A Terms
Under terms of the agreement, Amgen will pay up to $1 billion: $425 million in cash at closing and up to $575 million in additional payments upon the achievement of certain regulatory and sales milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
34 Commerce Way
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
The Company is developing a new class of potent biologics for the treatmentof cancer and prevention of infectious disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philip Astley-Sparke
Chief Financial Officer
Stephen Gorgol
Chief Medical Officer
Howard Goldsweig
Chief Technical Officer
Robert Coffin
VP - Bus. Development
Pamela Esposito
VP - Manufacturing
Paul Bullock
VP - Operations
Timothy Hanke
VP - Operations
Lance Weed
VP - Product Management
Colin Love
VP - Regulatory Affairs
Anne Woodland
Browse more venture capital transactions:
Prev: 1/25/2011: Solar Universe venture capital transaction
Next: 1/25/2011: Graphic.ly venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs